Completed PHASE2 INTERVENTIONAL 2-arm NCT02401529

Effect of Steroids on Post-tonsillectomy Morbidities

Sponsor: King Fahd General Hospital

Conditions Postoperative Nausea and Vomiting Postoperative Pain

Interventions IV dexamethasone IV saline Oral prednisolone Paracetamol

Updated 5 times since 2017 Last updated: Jun 20, 2015 Started: Jan 31, 2013 Primary completion: Mar 31, 2014 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02401529, this PHASE2 trial focuses on Postoperative Nausea and Vomiting and Postoperative Pain and remains completed. Sponsored by King Fahd General Hospital, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King Fahd General Hospital

Data source: King Fahd General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.